A spurt in demand for the latest passenger jets helped Boeing (BA) extend the lead over its European rival Airbus in the early part of the year. As a further indication of the ongoing race for market supremacy between the world’s largest aircraft makers, Boeing and Airbus recently forged tie-ups with Embraer and Bombardier respectively to ramp up their portfolios.
The impressive performance on the order front in the first half is anticipated to reflect in Boeing’s second-quarter revenue, which is scheduled to be announced on July 25. Media reports Tuesday revealed that Boeing received a total of 460 new orders in the first six months of 2018, more than double the number of orders booked by Airbus during the same period.
RELATED: Boeing, Embraer forge tie-up
The company also registered a marked increase in deliveries in the first half, primarily owing to strong demand for the 737 and 787 jet models. Total deliveries increased 7.4% annually to 378 units during the period, when the production of the 737 narrow-body model was raised. There was a similar increase in the delivery of Dreamliner, while the 777 witnessed a sharp fall. In the second quarter, the company delivered 194 aircraft, up 6% compared to last year.
The impressive performance on the order front in the first half is anticipated to reflect in Boeing’s second-quarter revenue
According to reports, Boeing is planning to raise the monthly output of 737s by 10% to 52 units in the second half, and further to 57 units in 2019. As per the current estimates, the Chicago-based company will beat Airbus in aircraft deliveries for the sixth consecutive year in 2018.
RELATED: Boeing plans hypersonic aircraft
In the run-up to the Farnborough Airshow to be held in the UK next week, Boeing has already clinched some major deals, including an $8.8-billion order for 75 jets from India-based aviation firm Jet Airways, a $5.6-billion order from Bamboo Airways of Vietnam and a high-value contract from FedEx (FDX) for the supply of 24 freighters.
The Boeing stock has been on a roller-coaster ride in recent months, gaining nearly 17% since the beginning of the year and hitting an all-time high in June. The stock traded higher throughout Tuesday and was up 1.5% at the close, maintaining the uptrend that began last week.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on